Frequency, severity and timing of common adverse events (AEs) with maintenance olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

Ursula Matulonis, Michael Friedlander, Andreas Du Bois, Charlie Gourley, Ignace Vergote, Gordon JS Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra, Daniela Matei, Anitra Fielding, Emma McMurtry, Stuart Spencer, Helen Mann, David Parry, Jonathan A Ledermann